A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants
Crossref DOI link: https://doi.org/10.1186/1546-0096-13-S1-O74
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rieber, N
Gavrilov, A
Hofer, L
Singh, A
Öz, H
Endres, T
Schäfer, I
Handgretinger, R
Hartl, D
Kümmerle-Deschner, J
Article History
First Online: 28 September 2015